Data / Form D filings / SOLENO THERAPEUTICS INC
SOLENO THERAPEUTICS INC: Form D filings
SOLENO THERAPEUTICS INC, a biotechnology company in Redwood City, CA, filed 12 Form D notices with the SEC between 2010 and 2023. The latest, on October 4, 2023, reports $60 million sold of a $60 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 203 REDWOOD SHORES PARKWAY, SUITE 500, Redwood City, CA, 94065
- Phone
- (650) 213-8444
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1484565
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 4, 2023 | New notice | $59,988,250 | $59,988,250 | 14 | Oct 2, 2023 | sec.gov | |
| Dec 22, 2017 | New notice | $15,000,006 | $15,000,006 | 16 | Dec 15, 2017 | sec.gov | |
| Feb 8, 2017 | New notice | $17,000,000 | $602,083 | $16,397,917 | 1 | Jan 27, 2017 | sec.gov |
| Jul 6, 2016 | New notice | $13,780,000 | $3,151,000 | $10,629,000 | 3 | Jul 5, 2016 | sec.gov |
| Oct 22, 2015 | New notice | $10,000,000 | $4,555,000 | $5,445,000 | 3 | Oct 15, 2015 | sec.gov |
| Oct 21, 2015 | New notice | $10,000,000 | $1,434,194 | $8,565,806 | 1 | Aug 13, 2015 | sec.gov |
| Mar 11, 2015 | New notice | $3,684,438 | $3,684,438 | 8 | Mar 5, 2015 | sec.gov | |
| Aug 13, 2012 | Amendment | $5,193,532 | $5,017,396 | $176,136 | 17 | Jan 17, 2012 | sec.gov |
| Jan 25, 2012 | New notice | $2,000,200 | $1,893,202 | $106,998 | 17 | Jan 17, 2012 | sec.gov |
| Nov 19, 2010 | New notice | $2,000,201 | $1,892,464 | $107,737 | 16 | Nov 10, 2010 | sec.gov |
| Mar 19, 2010 | Amendment | $4,700,470 | $3,309,227 | $1,391,243 | 28 | Feb 10, 2010 | sec.gov |
| Feb 24, 2010 | New notice | $4,700,470 | $3,097,214 | $1,603,256 | 12 | Feb 10, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew Pauls | Director | |
| Anish Bhatnagar | Executive Officer, Director | |
| James Mackaness | Executive Officer | |
| Andrew Sinclair | Director | |
| Ernest Mario | Director | |
| Birgitte Volck | Director | |
| Gwen Melincoff | Director | |
| William Harris | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Oct 2, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SOLENO THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.